Share

Eli Lilly CEO talks partnering with AbCellera Biologics to co-develop a coronavirus cure

"We're starting this because we believe it could work," Eli Lilly CEO David Ricks told CNBC in explaining the company's partnership with AbCellera Biologics.
08:07
Fri, Mar 13 20207:04 PM EDT